Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-06

Clinical Trial Update: Trial of Dexamethasone for Traumatic Brain Injured Patients With Brain Contusions and Pericontusional Edema [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dexamethasone for traumatic brain injury with brain contusions and pericontusional edema has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Jon Pérez Bárcena | Conditions: Traumatic Brain Injury, Cerebral Edema | Phase 3 | Status: TERMINATED